Publication | Closed Access
Zolmitriptan (a 5-HT1B/1D receptor agonist with central action) does not increase symptoms in obsessive compulsive disorder
24
Citations
0
References
2000
Year
5-Ht1b/1d Receptor AgonistPsychiatryAddictionObsessive Compulsive DisorderObsessive-compulsive DisorderMedicinePsychotropic MedicationPsychopharmacologyNeuropharmacologyCentral ActionSocial SciencesCompulsive BehaviorNeurosciencePharmacologyPsychopathology
No additional data available for this publication yet. Check back later!